Developer docs
API playgroundTry for free, no card

Search company profiles

Vita Life Sciences

Full company profile

uuid003jvva

Namestring
Vita Life Sciences
Company typeenum
Private
Founded yearint
1947
Descriptiontext

Vita Life Sciences is an Australian public consumer health company that manufactures and distributes dietary supplements, vitamins, minerals, herbs, and superfoods. Founded in 1947 and headquartered in Sydney, the company is listed on the Australian Securities Exchange under the ticker VLS and operates with a workforce of 101–250 employees. Its product portfolio is positioned to serve consumers across all age groups, spanning the major supplement categories from foundational vitamins and minerals to herbal preparations and functional superfoods. The company has operated continuously for 78 years under the same corporate identity, indicating a long-established position in the Australian and regional consumer wellness market.

The company's commercial scope places it within the broader bone and joint health supplements segment, which third-party market sizing projects to reach $24.12 billion by 2030 at a 10.0% CAGR, driven by formulation innovation, e-commerce expansion, and rising consumer interest in personalized nutrition. As a listed CPG manufacturer, Vita Life Sciences generates revenue through the production and sale of nutritional products distributed through the channels typical of the Australian supplements industry — pharmacy, health-food retail, and mass-market consumer outlets. The breadth of its SKU base across multiple supplement categories suggests a portfolio rather than single-product revenue model, though the source material does not disclose specific channel mix, customer concentration, or pricing structure.

The input data is materially incomplete on several dimensions that would normally inform a full investment thesis. The company website was inaccessible at the time of capture, yielding no product, leadership, or operational detail. No management team, distribution channel, marketing channel, partnership, patent, certification, or recent M&A disclosures are present in the source material. A financial series is provided but denominated in a unit that is dimensionally implausible for a 101–250 employee company, so it is not directly interpretable. The description above is therefore limited to what is firmly grounded in the firmographic profile and the available market-context source.

Short descriptiontext

Vita Life Sciences is an Australian public company (ASX:VLS) that manufactures and distributes dietary supplements, vitamins, minerals, herbs, and superfoods for consumers across all age groups, founded in 1947 and headquartered in Sydney.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersSydney, Australia
HQ citystring
Sydney
HQ countrystring
Australia
HQ regionstring
Oceania
Markets served

Serves global market

Keyword5 values
dietary supplements, vitamin products, herbal supplements, mineral supplements, nutritional superfoods
Industry5 codes
1Multivitamins & Daily Packs
CodeCRADAGACPrimaryYes
2Vitamins & Minerals (Single Nutrients)
CodeCRADAGABPrimaryNo
3Herbal & Botanical Supplements
CodeCRADAGADPrimaryNo
4Children’s Vitamins & Supplements
CodeCRADAGAJPrimaryNo
5Women’s Health Supplements (Prenatal, Menopause, Hormonal)
CodeCRADAGAKPrimaryNo
NAICS code1 code
  • Food Manufacturing311
SIC code1 code
  • Medicinal Chemicals & Botanical Products2833
Product category
Dietary Supplements
No data
Cost components4 values
Supply Chain, Operations, Personnel, Marketing or Sales
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Vita Life Sciences manufactures and sells dietary supplements including vitamins, minerals, herbs, and superfoods formulated for consumers across all age groups. The company operates as a branded nutritional products manufacturer in the broader supplements market, which is growing due to formulation innovation, e-commerce expansion, and personalized nutrition demand.

Differentiator
Functional benefit
Problem solved
Product and service1 record
1Dietary Supplements (vitamins, minerals, herbs, and superfoods)
Scale indicator1 record

Each record includes

Type, Value, Description, Source

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight2 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Global supplements and nutrition company with a broad vitamins, minerals and herbal product portfolio, competing with Vita Life Sciences in the multi-category supplement space at much larger scale.

TypeDirect peer
Description

Australian supplements manufacturer producing brands including Nature's Own and Cenovis, directly competing with Vita Life Sciences in vitamins, minerals and herbal products through pharmacy and mass retail.

TypeDirect peer
Description

Practitioner-channel nutritional supplements manufacturer with a broad vitamins, minerals and herbal product line that overlaps with Vita Life Sciences' multi-category supplement offering.

TypeDirect peer
Description

Large US-based vitamins, herbal and supplements brand with global distribution, comparable in product breadth (vitamins, minerals, herbs) and channel mix to Vita Life Sciences.

TypeEmerging player
Description

Multi-level-marketing supplements and nutrition company selling vitamins and nutrition products to consumers globally; partial overlap with Vita Life Sciences' vitamins and nutritional supplements portfolio via direct-to-consumer channels.

TypeDirect peer
Description

Australia's largest listed supplements brand (ASX:BKL), manufacturing and selling vitamins, minerals, herbal and nutritional supplements across similar retail and pharmacy channels to Vita Life Sciences.

TypeBroad incumbent
Description

Global specialty retailer and manufacturer of vitamins, minerals and sports nutrition supplements; overlaps with Vita Life Sciences across product categories and retail/pharmacy channels.

TypeBroad incumbent
Description

Large consumer healthcare company spun out of GSK whose portfolio includes vitamins, minerals and nutritional supplements (e.g., Centrum), competing broadly with Vita Life Sciences' category set.

TypeDirect peer
Description

Australian-headquartered premium supplements brand owned by H&H Group, offering vitamins, herbal and sports supplements across the same pharmacy, grocery and DTC channels as Vita Life Sciences.

TypeBroad incumbent
Description

Global pharmaceutical and consumer health company with nutritional supplements lines; overlapping with Vita Life Sciences as a broad incumbent in vitamins and mineral supplements.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Vita Life Sciences

Dietary Supplementsvitalifesciences.com

Vita Life Sciences is an Australian public company (ASX:VLS) that manufactures and distributes dietary supplements, vitamins, minerals, herbs, and superfoods for consumers across all age groups, founded in 1947 and headquartered in Sydney.

What Vita Life Sciences does

Vita Life Sciences is an Australian public consumer health company that manufactures and distributes dietary supplements, vitamins, minerals, herbs, and superfoods. Founded in 1947 and headquartered in Sydney, the company is listed on the Australian Securities Exchange under the ticker VLS and operates with a workforce of 101–250 employees. Its product portfolio is positioned to serve consumers across all age groups, spanning the major supplement categories from foundational vitamins and minerals to herbal preparations and functional superfoods. The company has operated continuously for 78 years under the same corporate identity, indicating a long-established position in the Australian and regional consumer wellness market.

The company's commercial scope places it within the broader bone and joint health supplements segment, which third-party market sizing projects to reach $24.12 billion by 2030 at a 10.0% CAGR, driven by formulation innovation, e-commerce expansion, and rising consumer interest in personalized nutrition. As a listed CPG manufacturer, Vita Life Sciences generates revenue through the production and sale of nutritional products distributed through the channels typical of the Australian supplements industry — pharmacy, health-food retail, and mass-market consumer outlets. The breadth of its SKU base across multiple supplement categories suggests a portfolio rather than single-product revenue model, though the source material does not disclose specific channel mix, customer concentration, or pricing structure.

The input data is materially incomplete on several dimensions that would normally inform a full investment thesis. The company website was inaccessible at the time of capture, yielding no product, leadership, or operational detail. No management team, distribution channel, marketing channel, partnership, patent, certification, or recent M&A disclosures are present in the source material. A financial series is provided but denominated in a unit that is dimensionally implausible for a 101–250 employee company, so it is not directly interpretable. The description above is therefore limited to what is firmly grounded in the firmographic profile and the available market-context source.

Vita Life Sciences firmographics

Firmographics
Name
Vita Life Sciences
Website
https://vitalifesciences.com
Company type
Private
Founded year
1947
Operating status
Operating
Headcount range
101–250 employees
Short description
Vita Life Sciences is an Australian public company (ASX:VLS) that manufactures and distributes dietary supplements, vitamins, minerals, herbs, and superfoods for consumers across all age groups, founded in 1947 and headquartered in Sydney.
Ownership category
akta.pro rank

Vita Life Sciences industry classification

Industry
Product category
Dietary Supplements
NAICS
Food Manufacturing (311)
SIC
Medicinal Chemicals & Botanical Products (2833)
akta.pro primary industry
Multivitamins & Daily Packs (CRADAGAC)
akta.pro secondary industries
Vitamins & Minerals (Single Nutrients) (CRADAGAB), Herbal & Botanical Supplements (CRADAGAD), Children’s Vitamins & Supplements (CRADAGAJ), Women’s Health Supplements (Prenatal, Menopause, Hormonal) (CRADAGAK)

Keywords

  • Dietary supplements
  • Vitamin products
  • Herbal supplements
  • Mineral supplements
  • Nutritional superfoods

Where Vita Life Sciences is headquartered

Location

Headquarters

HQ city
Sydney
HQ country
Australia
HQ region
Oceania

Markets served

Vita Life Sciences business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Marketing or Sales

Vita Life Sciences product offering

Product offering

Core offering

Vita Life Sciences manufactures and sells dietary supplements including vitamins, minerals, herbs, and superfoods formulated for consumers across all age groups. The company operates as a branded nutritional products manufacturer in the broader supplements market, which is growing due to formulation innovation, e-commerce expansion, and personalized nutrition demand.

Differentiator

Problem solved

Functional benefit

Products and services

  • Dietary Supplements (vitamins, minerals, herbs, and superfoods)

Companies that use Vita Life Sciences

Customer profile

Ideal customer profiles1 record

Vita Life Sciences technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Vita Life Sciences partnerships and signals

Strategic signal

Scale indicators1 record

Recent moves4 records

Expansion highlights2 records

Vita Life Sciences competitors and assessment

Company assessment

Broad incumbents

  • Herbalife: Global supplements and nutrition company with a broad vitamins, minerals and herbal product portfolio, competing with Vita Life Sciences in the multi-category supplement space at much larger scale.
  • GNC Holdings: Global specialty retailer and manufacturer of vitamins, minerals and sports nutrition supplements; overlaps with Vita Life Sciences across product categories and retail/pharmacy channels.
  • Haleon: Large consumer healthcare company spun out of GSK whose portfolio includes vitamins, minerals and nutritional supplements (e.g., Centrum), competing broadly with Vita Life Sciences' category set.
  • Sanofi Consumer Healthcare: Global pharmaceutical and consumer health company with nutritional supplements lines; overlapping with Vita Life Sciences as a broad incumbent in vitamins and mineral supplements.

Direct peers

  • Pharmacare: Australian supplements manufacturer producing brands including Nature's Own and Cenovis, directly competing with Vita Life Sciences in vitamins, minerals and herbal products through pharmacy and mass retail.
  • Metagenics: Practitioner-channel nutritional supplements manufacturer with a broad vitamins, minerals and herbal product line that overlaps with Vita Life Sciences' multi-category supplement offering.
  • Nature's Way: Large US-based vitamins, herbal and supplements brand with global distribution, comparable in product breadth (vitamins, minerals, herbs) and channel mix to Vita Life Sciences.
  • Blackmores: Australia's largest listed supplements brand (ASX:BKL), manufacturing and selling vitamins, minerals, herbal and nutritional supplements across similar retail and pharmacy channels to Vita Life Sciences.
  • Swisse Wellness: Australian-headquartered premium supplements brand owned by H&H Group, offering vitamins, herbal and sports supplements across the same pharmacy, grocery and DTC channels as Vita Life Sciences.

Emerging players

  • Nu Skin Enterprises: Multi-level-marketing supplements and nutrition company selling vitamins and nutrition products to consumers globally; partial overlap with Vita Life Sciences' vitamins and nutritional supplements portfolio via direct-to-consumer channels.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

Vita Life Sciences financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Vita Life Sciences leadership team

Management profile

Number of profiles

Vita Life Sciences funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Vita Life Sciences M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Vita Life Sciences

What does Vita Life Sciences do?

Vita Life Sciences manufactures and sells dietary supplements including vitamins, minerals, herbs, and superfoods formulated for consumers across all age groups. The company operates as a branded nutritional products manufacturer in the broader supplements market, which is growing due to formulation innovation, e-commerce expansion, and personalized nutrition demand.

When was Vita Life Sciences founded?

Vita Life Sciences was founded in 1947. It employs 101 to 250 people.

Where is Vita Life Sciences based?

Vita Life Sciences is headquartered in Sydney, Australia, in the Oceania region.

Who are Vita Life Sciences's main competitors?

Broad incumbents on record are Herbalife, GNC Holdings, Haleon and Sanofi Consumer Healthcare. Direct peers are Pharmacare, Metagenics, Nature's Way, Blackmores and Swisse Wellness. Nu Skin Enterprises is listed as an emerging player.

Does Vita Life Sciences have an API?

No public API is recorded for Vita Life Sciences.

What industry is Vita Life Sciences in?

Vita Life Sciences's product category is Dietary Supplements. Its primary akta.pro industry code is CRADAGAC, Multivitamins & Daily Packs, with a secondary code of CRADAGAB, Vitamins & Minerals (Single Nutrients). Its NAICS code is 311 and its SIC code is 2833.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
YahooTop 3 Australian Biotech Stocks To Watch In October 2026The article profiles Vita Life Sciences and Clinuvel Pharmaceuticals as Australian biotech stocks to watch in October 2026. Vita Life Sciences has a market cap of A$150 million with a 13.5x P/E, while Clinuvel's A$400 million market cap relies heavily on its SCENESSE therapy. Both face concentration risks and unresolved pricing power concerns.Yahoo3 Australian Dividend Stocks With Yields Up To 8%The article profiles two Australian dividend stocks, Vita Life Sciences and Peet, both offering yields above 5%. Vita Life Sciences reports a 5% yield with 19.8% earnings growth, while Peet trades at a 7.2x P/E with recurring fee income. The piece notes valuation risk and recommends a full analysis report.Simply Wall St3 Australian Dividend Stocks To Own In October 2026Three Australian dividend stocks—Vita Life Sciences, Peet, and Sandfire Resources—are profiled for October 2026, with yields above 5% and P/E ratios below peers. Vita Life Sciences offers a 5.07% yield, Peet a fully franked interim dividend, and Sandfire Resources benefits from copper demand. Future funding pressures and ownership shifts could affect payout policies.Yahoo3 Great Australian Biotech Stocks With P E Under 14Three Australian biotech stocks with P/E under 14 are profiled: Vita Life Sciences, Clinuvel Pharmaceuticals, and Mayne Pharma Group. Vita Life Sciences reports A$43 million from Australia and A$46 million from Malaysia and Singapore, with a 13.4x P/E. Clinuvel's revenue is heavily dependent on SCENESSE, while Mayne Pharma's women's health portfolio shows growth potential.Simply Wall StVita Life Sciences And 2 Other Australian Dividend StocksVita Life Sciences, Peet, and Sandfire Resources are profiled as high-yield Australian dividend stocks. Vita Life Sciences offers a 5.07% yield with A$43 million Australian revenue, Peet has a 5.07% yield with A$305 million development revenue, and Sandfire Resources has a 5.07% yield with US$745 million Motheo revenue. The article notes pending ownership shifts and production ramp-ups as key risks.YahooAustralian Dividend Stocks To Own In September 2026The article highlights Vita Life Sciences and Peet as Australian dividend stocks with yields above 5%, citing their revenue, market value, and financial metrics. Vita Life Sciences offers a 5.07% yield with a 13.4x P/E, while Peet carries a high yield on recurring fees and net income. Both payouts depend on balance sheet pressures.AInvestVita Life Sciences: The Buyback Math Most Investors Skip PastVita Life Sciences authorized a 15% share buyback (8.1M shares) through 2027, with slow execution but AUD 33.7M cash reserves. The company generates AUD 15.9M free cash flow and trades at 7x EV/EBITDA despite 19% revenue growth. Risks include China strategy execution and margin pressures.cairnspostASX healthcare stocks focusing on mitochondrial healthASX-listed healthcare companies including EZZ Life Science, Vita Life Sciences, Alterity Therapeutics, and Neurizon Therapeutics are increasingly targeting mitochondrial health through consumer supplements and clinical therapies for ageing and neurodegenerative diseases. EZZ is co-funding research on a combination of compounds to prevent mitochondrial decline, while Alterity and Neurizon are advancing late-stage trials for treatments involving cellular maintenance pathways in conditions like multiple system atrophy and ALS.KalkineVita Life Sciences’ 6.95% Yield: Could Healthcare Expansion Fuel Future Dividends?Vita Life Sciences Limited (ASX: VLS), a small-cap health-supplements company, is discussed in relation to its approximately 6.95% indicated dividend yield as of mid-2026, supported by a history of fully franked dividends. The article examines the company's business model, which centers on brands such as Herbs of Gold, and its operations across Australia and South-East Asian markets including Malaysia and Singapore.openPR.comSegmentation, Major Trends, and Competitive Overview of the Bone and Joint Health Supplements MarketThe bone and joint health supplements market is projected to reach $24.12 billion by 2030, growing at a compound annual growth rate of 10.0%, driven by innovations in supplement formulations, e-commerce expansion, and rising interest in personalized nutrition. In July 2023, France-based Sanofi acquired US-based Qunol, enhancing its vitamin, mineral, and supplement portfolio with Qunol's turmeric-based joint health products. In April 2025, US-based Qualia Life Sciences launched Qualia Joint Health, featuring advanced ingredients such as native type II collagen and eggshell membrane to support joint health.